Based on the profile of participants enrolled in retatrutide trials to date, the drug appears most relevant to adults living with obesity (BMI 30 kg/m) or those who are overweight (BMI 27 kg/m) with weight-related health conditions such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea
Where to inject: The patient leaflet advises keeping a 5 cm distance from your belly button
Back Underwerth, D (June 2017) 'How does obesity cause cancer?', MD Anderson Center
For minor skin irritation at injection sites, keep the area clean and consider using gentle moisturizers as recommended by your provider
Research documents effects on 31.2% of the human genome, modulating over 4,000 genes involved in repair, inflammation, and cellular function
A baseline evaluation at Stanford Hearing gives your care team a clear starting point